Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1299

3'-sialyllactose sodium salt

Intended Use: Intended for use as an ingredient in non-exempt infant formula for term infants at a maximum use level of 0.28 g/L, as consumed, and in other food categories at other specified maximum levels.
Basis: Scientific procedures
Notifier: Synaura Biotechnology (Shanghai) Co., Ltd.
Notifier Address: Building 2, Lane 500, Furong Hua Road, Pudong New Area
Shanghai
CHINA
FDA's Letter: Pending
-
-